Bicnu and Stools - watery - a phase IV clinical study of FDA data

Summary:

Stools - watery is reported as a side effect among people who take Bicnu (carmustine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Alkeran, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Stools - watery when taking Bicnu. It is created by eHealthMe based on reports of 1,133 people who have side effects when taking Bicnu from the FDA, and is updated regularly.

What is Bicnu?

Bicnu has active ingredients of carmustine. eHealthMe is studying from 1,135 Bicnu users. Check the latest studies of Bicnu.

What is Stools - watery?

Stools - watery is found to be associated with 4,697 drugs and 5,937 conditions by eHealthMe. Check the latest studies of Stools - watery.

On Jul, 10, 2026

1,133 people reported to have side effects when taking Bicnu.
Among them, 59 people (5.21%) have Stools - watery.

Among these 59 people:

How long have people been on Bicnu when they have Stools - watery? *

What is the gender of people who have Stools - watery when taking Bicnu? *

female: 42 %
male: 58 %

What is the age of people who have Stools - watery when taking Bicnu? *

What are other drugs people take besides Bicnu? *

What are other side effects people have besides Stools - watery? *

Fever: 17 people, 28.81%
Mucosal Inflammation (infection of mucous membrane): 15 people, 25.42%
Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 10 people, 16.95%
Nausea (feeling of having an urge to vomit): 9 people, 15.25%
Febrile Neutropenia (fever with reduced white blood cells): 8 people, 13.56%
Leukopenia (less number of white blood cells in blood): 8 people, 13.56%
Aplasia (defective development or congenital absence of an organ or tissue): 7 people, 11.86%
Thrombocytopenia (decrease of platelets in blood): 7 people, 11.86%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 11.86%
Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 11.86%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 10 people, 16.95%
Lymphoma (cancer that begins in immune system cells): 7 people, 11.86%
Burkitt Lymphoma (cancer of the lymphatic system): 7 people, 11.86%
Haematopoietic Stem Cell Mobilisation: 6 people, 10.17%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 8.47%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 5 people, 8.47%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 5 people, 8.47%
High Grade B-Cell Lymphoma Burkitt-Like Lymphoma (cancer of b cells): 4 people, 6.78%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 4 people, 6.78%
Nausea And Vomiting: 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Bicnu and have Stools - watery?

- Check whether Stools - watery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bicnu:

Bicnu (1,135 reports)

Stools - watery treatments and more:

Stools - watery (756,290 reports)

Browse all side effects of Bicnu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stools - watery:

Stools - watery (4,697 drugs)

Browse all the conditions that are associated with Stools - watery:

Stools - watery (5,937 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Bicnu) and Bicnu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.